372 related articles for article (PubMed ID: 21864231)
1. Anticancer activity of bisphosphonates in breast cancer.
Gnant M
Anticancer Agents Med Chem; 2012 Feb; 12(2):114-22. PubMed ID: 21864231
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates: prevention of bone metastases in breast cancer.
Gnant M; Dubsky P; Hadji P
Recent Results Cancer Res; 2012; 192():65-91. PubMed ID: 22307370
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Hadji P; Coleman RE; Wilson C; Powles TJ; Clézardin P; Aapro M; Costa L; Body JJ; Markopoulos C; Santini D; Diel I; Di Leo A; Cameron D; Dodwell D; Smith I; Gnant M; Gray R; Harbeck N; Thurlimann B; Untch M; Cortes J; Martin M; Albert US; Conte PF; Ejlertsen B; Bergh J; Kaufmann M; Holen I
Ann Oncol; 2016 Mar; 27(3):379-90. PubMed ID: 26681681
[TBL] [Abstract][Full Text] [Related]
4. Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature.
Gnant M; Clézardin P
Cancer Treat Rev; 2012 Aug; 38(5):407-15. PubMed ID: 21983264
[TBL] [Abstract][Full Text] [Related]
5. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Brufsky A
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
[TBL] [Abstract][Full Text] [Related]
6. Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
Gnant M
Breast Dis; 2011; 33(2):71-81. PubMed ID: 22142663
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and breast cancer prevention.
Chlebowski RT; Col N
Anticancer Agents Med Chem; 2012 Feb; 12(2):144-50. PubMed ID: 21864227
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates and breast cancer incidence and recurrence.
Chlebowski RT; Col N
Breast Dis; 2011; 33(2):93-101. PubMed ID: 22142660
[TBL] [Abstract][Full Text] [Related]
10. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Lipton A
Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid: past, present and future roles in cancer treatment.
Saad F
Future Oncol; 2005 Apr; 1(2):149-59. PubMed ID: 16555985
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
Li J; Rugo HS
Breast Dis; 2011; 33(2):83-92. PubMed ID: 22142661
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bone metastases and management of bone health in early breast cancer.
Gnant M; Hadji P
Breast Cancer Res; 2010; 12(6):216. PubMed ID: 21172067
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates in the adjuvant treatment of breast cancer.
Winter MC; Coleman RE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):135-45. PubMed ID: 23207072
[TBL] [Abstract][Full Text] [Related]
15. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates in breast cancer: teaching an old dog new tricks.
Winter MC; Coleman RE
Curr Opin Oncol; 2009 Nov; 21(6):499-506. PubMed ID: 19730102
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid use in cancer patients: more than just supportive care?
Coleman R; Cook R; Hirsh V; Major P; Lipton A
Cancer; 2011 Jan; 117(1):11-23. PubMed ID: 21235033
[TBL] [Abstract][Full Text] [Related]
18. The endocrine influence on the bone microenvironment in early breast cancer.
Wilson C; Brown H; Holen I
Endocr Relat Cancer; 2016 Dec; 23(12):R567-R576. PubMed ID: 27687494
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates as treatment of bone metastases.
Holen I; Coleman RE
Curr Pharm Des; 2010; 16(11):1262-71. PubMed ID: 20166976
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials.
Gnant M
Curr Cancer Drug Targets; 2009 Nov; 9(7):824-33. PubMed ID: 20025570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]